Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Interpace Biosciences Inc
IDXGCurrent price
1.58 USD
0 USD (0.00%)
Last closed
1.5 USD
Company
www.interpace.com
ISIN
US46062X3035
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
OTCQX
Capitalization
6 503 579 USD
Yield for 12 month
+43.64 %
1Y
3Y
5Y
10Y
15Y
IDXG
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test for the diagnosis and prognosis of pancreatic cancer; PanDNA, a molecular only version of PancraGEN; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company primarily serves physicians, cancer center, clinics, laboratories, pathology groups, and hospitals. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey. Address: Waterview Plaza, Parsippany, NJ, United States, 07054
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11 USDP/E ratio
2.1765Dividend Yield
–Current Year
+40 214 000 USD
Last Year
+31 838 000 USD
Current Quarter
+12 042 000 USD
Last Quarter
+10 273 000 USD
Current Year
+23 904 000 USD
Last Year
+18 231 000 USD
Current Quarter
+7 431 000 USD
Last Quarter
+6 071 000 USD
Key Figures IDXG
1 year
3 years
5 years
10 years
EBITDA
4 865 000 USD
Operating Margin TTM
PE Ratio
2.1765
Return On Assets TTM
19.17 %
PEG Ratio
–
Return On Equity TTM
-284.81 %
Wall Street Target Price
11 USD
Revenue TTM
41 675 000 USD
Book Value
-13.49 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
9.2 %
Dividend Yield
–
Gross Profit TTM
18 231 000 USD
Earnings per share
0.68 USD
Diluted Eps TTM
0.68 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
1107.4 %
Profit Margin
6.73 %
Dividend Analytics IDXG
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IDXG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
15.01.2020
Dividend Date
15.01.2020
Stock Valuation IDXG
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
2.1765
Forward PE
–
Enterprise Value Revenue
0.3089
Price Sales TTM
0.1561
Enterprise Value EBITDA
2.6876
Price Book MRQ
10.0372
Financials IDXG
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IDXG
For 52 weeks
0.78 USD
2.01 USD
50 Day MA
1.36 USD
Shares Short Prior Month
29 806
200 Day MA
1.36 USD
Short Ratio
0.19
Shares Short
47 355
Short Percent
1.18 %
BeatStart